Jpmorgan Chase & Co »

Adverum Biotechnologies shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Adverum Biotechnologies shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Adverum Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Adverum Biotechnologies held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adverum Biotechnologies by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $537 38 14.13

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Adverum Biotechnologies

VR Adviser
Vivo Capital
Logos Global Management
Vanguard Group
FMR
BML Capital Management
Franklin Resources
Commodore Capital
Morgan Stanley
5AM Venture Management
Laurion Capital Management
Assenagon Asset Management
BlackRock
Samsara BioCapital
Millennium Management

View all funds holding Adverum Biotechnologies